References
- Alberti , K. G. M. M. 1995 . Local research ethics committees . BMJ , 311 ( 7006 ) : 639 – 640 . [CSA]
- Al-Shahi , R. 2005 . Research ethics committees in the UK—The pressure is now on research and development departments . J R Soc Med , 98 ( 10 ) : 444 – 447 . [INFOTRIEVE] [CSA]
- Annas , G. J. 1999 . Why we need a national human experimentation agency . Account Res , 7 ( 2–4 ) : 293 – 302 . [INFOTRIEVE] [CSA]
- Campbell , E. G. , Weissman , J. S. , Clarridge , B. , Yucel , R. , Causiono , N. and Blumenthal , D. 2003 . Characteristics of Medical School Faculty Members Serving on Institutional Review Boards: Results of a National Survey . Acad Med , 78 ( 8 ) : 831 – 836 . [INFOTRIEVE] [CSA]
- Capron , A. M. 1999 . Is national, independent oversight needed for the protection of human subjects? . Account Res , 7 ( 2–4 ) : 283 – 92 . [INFOTRIEVE] [CSA]
- Edgar , H. and Rothman , D. J. 1995 . The institutional review board and beyond: future challenges to the ethics of human experimentation . Milbank Q , 73 ( 4 ) : 489 – 506 . [INFOTRIEVE] [CSA]
- Emanuel, E. J. (2002). Institutional Review Boards. Presentation to the President’s Council on Bioethics http://www.webcitation.org/query?id=96323
- Evans, D., Smith, M., and Willen, L. (2005). Big pharma’s shameful secret, Bloomberg Markets http://www.webcitation.org/query?id=96195
- Getz , K. and Zisson , S. 2003 . Clinical grants market decelerates . CenterWatch , 10 : 4 – 5 . [CSA]
- Good Clinical Practice. (1996). International Conference On Harmonisation Of Technical Requirements For Registration Of Pharmaceuticals For Human Use (ICH)
- Grob, G. (May 3, 2000). Protecting Human Subjects: Status of Recommendations. Testimony Before the House Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy and Human Resources http://www.webcitation.org/query?id=96193
- Guidance for industry. (2001). E 10. Choice of control group and related issues in clinical trials. International Conference on Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) http://www.webcitation.org/query?id=96340 (Accessed: 14 February 2006 ).
- Mann , H. , London , A. J. and Mann , J. 2005 . Equipoise in the enhanced supression of the platelet IIb/IIIa receptor with integrilin trial (ESPRIT): a critical appraisal . Clin Trials , 2 ( 3 ) : 233 – 41 . discussion 242–243[INFOTRIEVE] [CSA]
- Mastroianni , A. C. 1999 . National, independent oversight: reinforcing the safety net for human subjects research . Account Res , 7 ( 2–4 ) : 303 – 9 . [PUBMED] [INFOTRIEVE] [CSA]
- O’Shea , J. C. , Hafley , G. E. , Greenberg , S. , Hasselblad , V. , Lorenz , T. J. , Kitt , M. M. , Stony , J. and Tcheng , J. E. 2001 . Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial . Jama , 285 ( 19 ) : 2468 – 73 . [CSA]
- Shamoo , A. E. 1994 . Our responsibilities toward persons with mental illness as human subjects in research . J Calif Alliance Ment Ill , 5 ( 1 ) : 14 – 6 . [INFOTRIEVE] [CSA]
- Shamoo , A. E. 1999 . Institutional review boards (IRBs) and conflict of interest . Account Res , 7 ( 2–4 ) : 201 – 12 . [INFOTRIEVE] [CSA]
- Tcheng , J. E. , Madan , M. , O’Shea , J. C. , Cohen , E. A. , Buller , C. E. , Lincoff , A. M. , Popma , J. J. , Teirstein , P. S. , Kitt , M. M. , Lorenz , T. J. , Greenberg , S. , Fost , N. and Califf , R. M. 2003 . Ethics and equipoise: rationale for a placebo-controlled study design of platelet glycoprotein IIb/IIIa inhibition in coronary intervention . J Interv Cardiol , 16 ( 2 ) : 97 – 105 . [INFOTRIEVE] [CSA]
- Wood , A. , Grady , C. and Emanuel , E. J. 2004 . Regional ethics organizations for protection of human research participants . Nat Med , 10 ( 12 ) : 1283 – 8 . [INFOTRIEVE] [CSA]